Fig. 1From: Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic diseaseCumulative incidences of the LEAD progression according to the GA variability indicators (1A-CV, 1B-VIM, 1C-ARV) and mean A1c (1D) tertiles (T1–T3) using the cox proportional hazards regression analysisBack to article page